- Telehealth visits
- Insurance plan information
Anthony Parish, MD
He | Him | HisPediatric Endocrinology- Telehealth visits
- Insurance plan information
Anthony Parish, MD
He | Him | HisPediatric Endocrinology- Telehealth visits
- Insurance plan information
On this page
About me
Dr. Anthony Parish is a specialist in caring for pediatric patients with hormonal conditions. He has particular interests in type 1 and type 2 diabetes, gender-affirming medicine, pediatric thyroid disease and adrenal gland disorders.
Subjects of Parish's research include health disparities for children and adolescents with type 1 diabetes, gender-affirming care and medical education.
Parish earned his medical degree from Rush Medical College. He completed a residency in pediatrics at Los Angeles General Medical Center, followed by a fellowship in pediatric endocrinology at Children's Hospital Los Angeles.
In addition to caring for patients, Parish is dedicated to improving access to health care for all children and also to advancing education in pediatric endocrinology. A North Bay native, he is proud to serve his community.
Education & training
Board certification
- Pediatric Endocrinology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Endocrinology, Children's Hospital Los Angeles
Residency
- Pediatrics, University of Southern California- Los Angeles
Internship
- Pediatrics, University of Southern California- Los Angeles
Degree
- MD, Rush Medical College
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Cushing Syndrome in Childhood.Opens in a new window
January 1, 2024
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.